Scilex Holding Company (NASDAQ: SCLX) confirmed June 15, 2026 as the payment date for distributing shares of Semnur Pharmaceuticals, Inc. (OTC: SMNR) common stock to its stockholders and other eligible security holders.

The dividend distribution applies to holders who owned Scilex securities as of the record date of June 1, 2026. Nasdaq set the ex-dividend date as June 16, 2026.

Eligible holders will receive one share of Semnur common stock for each share of Scilex common stock held, or for each share of common stock issuable upon exercise or conversion of other eligible securities according to their contractual rights.

Scilex, based in Palo Alto, California, focuses on acquiring, developing and commercializing non-opioid pain management products. The company's commercial products include ZTlido for neuropathic pain, ELYXYB for migraine treatment, and Gloperba for gout flare prevention.

Semnur Pharmaceuticals is a clinical-stage specialty pharmaceutical company developing non-opioid pain therapies. The company's primary product candidate is SP-102, a gel formulation administered epidurally for patients with chronic radicular pain and sciatica. Semnur is a majority-owned subsidiary of Scilex.

The information was disclosed in a company press release statement.